SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001558370-23-015347
Filing Date
2023-08-30
Accepted
2023-08-30 16:05:46
Documents
9

Document Format Files

Seq Description Document Type Size
1 S-3 tmb-20230830xs3.htm S-3 289572
2 EX-4.7 tmb-20230830xex4d7.htm EX-4.7 38357
3 EX-5.1 tmb-20230830xex5d1.htm EX-5.1 58043
4 EX-23.1 tmb-20230830xex23d1.htm EX-23.1 5222
5 EX-FILING FEES tmb-20230830xexfilingfees.htm EX-FILING FEES 61903
6 GRAPHIC tmb-20230830xex5d1001.jpg GRAPHIC 3671
7 GRAPHIC tmb-20230830xex5d1002.jpg GRAPHIC 3044
8 GRAPHIC tmb-20230830xs3001.jpg GRAPHIC 2974
9 GRAPHIC tmb-20230830xs3003.jpg GRAPHIC 10034
  Complete submission text file 0001558370-23-015347.txt   482159
Mailing Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540 609-538-8200
SOLIGENIX, INC. (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-274265 | Film No.: 231225289
SIC: 2834 Pharmaceutical Preparations